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19-Nortestosterone (NT) has been illegally used in horse racing to boost physical performance, and in animal husbandry to accel-
erate weight gain. To monitor the abuse of NT, our goal was to develop a commercial enzyme linked immunosorbent assay 
(ELISA) kit. For this purpose, hybridomas were prepared by fusing NS0 mouse myeloma cells with splenocytes isolated from 
immunized BALB/c mouse. Noncompetitive and competitive indirect ELISA were used to screen positive cell clones. To opti-
mize the indirect competitive ELISA (icELISA) method, various methanol concentrations in assay buffer were evaluated. Matrix 
effects in urine and spiking test were also investigated. Finally, five hybridoma cell lines named NT-1, NT-2, NT-3, NT-4 and 
NT-5 were screened out. The corresponding monoclonal antibodies (mAbs) were of the IgG1 isotype with a k light chain, and the 
antibody affinity of all mAbs were between 2.6×109 and 4.7×109 L/mol. The titer and IC50 values of purified ascites were in the 
range of 0.64×105−2.56×105 and 0.55–1.0 ng/mL, respectively. Based on the NT-1 hybridoma, a heterologous icELISA method 
was developed for the quantitative detection of NT in cattle urine. The dynamic range was from 0.004 to 85.8 ng/mL, with a de-
tection limit for the assay and IC50 values of 0.002 and 0.55 ng/mL, respectively. Except for a high cross-reactivity (62%) to α-NT, 
negligible cross-reactivity to other compounds was observed. After optimization, 10% of methanol was used in the assay buffer, 
and a 20-fold dilution in cattle urine gave an inhibition curve almost the same as that in phosphate buffered saline. The correlation 
coefficient between the established icELISA and LC-MS/MS method was 0.9871. The results showed that the established heter-
ologous icELISA method provides an excellent alternative for the detection of NT residues in food producing animals. 
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19-Nortestosterone (17β-hydroxyestr-4-en-3-one, NT), also 
named nandrolone, is a xenobiotic with androgenic and an-
abolic properties known since the 1930s. Recently, it has 
been found endogenously in a number of species [1]. In the 
1950s, the recognition of the growth promoting property of 
NT led to it being used to accelerate meat production. It can 
enhance lean tissue growth, reduce fat deposition, increase 
the weight gain and feed conversion efficiency of animals 
[2–4]. Administration is usually by intramuscular injection 
of the esterified drug in suspension with benzyl alcohol and 
arachis oil, or inserted into the fleshy part of the ear. The 
hormone is gradually released over a period of 50 d or so, to 
ensure a relatively constant and slightly elevated level in the 
animal’s blood [5]. Because of its androgenic activity, NT 
has also been employed as a doping agent for athletes and in 
horse racing to increase muscle mass and physical strength, 
and boost physical performance [4,6]. 
But studies show NT and its metabolite residue in meat 
produce a series of adverse effects, including peliosis hepa-
titis, hypoproteinemia, adrenal atrophy, dyskeratosis, re-
duced semen production, testicle shrinkage, menstrual cycle 
disorder, masculinization, cerebral dysfunction, emotional 
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instability and other side effects [7–10]. Consequently the 
use of natural and synthetic hormones for growth promotion 
purposes in meat-producing animals has been prohibited in 
the European Community since 1986 to protect consumers 
from possible developmental, neurobiological, genotoxic 
and carcinogenic effects [11]. NT and its esters, as well as 
metabolites are also prohibited in animal food and animal 
drugs and is on the banned compounds list in China (Notice 
No. 193 of the Ministry of Agriculture in April 2002). 
However, illegal use of NT as a growth promoter has been 
widely reported throughout Europe [2] and in China, thus 
prompting continuous surveillance to control its abuse. 
Traditionally, NT residue analysis has relied upon clas-
sical analytical methods, such as gas chromatography cou-
pled to mass spectrometric (GC–MS) [6,12–14], liquid 
chromatography coupled to mass spectrometric (LC–MS) 
[15–17], and other quantitative methods. Chromatographic 
techniques generally require highly skilled personnel, labo-
rious sample pretreatment and high-cost, complex equip-
ment. Therefore, they are not suitable for routine analysis of 
a large number of samples or on-site determinations. Im-
munological techniques are increasingly considered as al-
ternative and/or complementary methods for residue analy-
sis because of their simplicity, cost-effectiveness, portability, 
and high sample throughput. 
Our main goal was to produce high-sensitivity monoclo-
nal antibodies displaying excellent affinity and specificity 
for NT, and optimize the indirect competitive ELISA pro-
tocols based on selected monoclonal antibodies. This work 
potentially optimizes the pre-treatment procedures for 
LC–MS and GC–MS detection, and lays a solid foundation 
for NT-kit and test strip development. 
1  Materials and methods 
1.1  Materials and chemicals   
19-Nortestosterone (NT), 17a, 19-nortestosterone (a-NT), es-
tradiol, trenbolone, methyltestosterone and clostebol were 
purchased from Dr. Ehrenstorfer Company (Germany). 
NT-17-succinic anhydride ester-BSA (NT-17-BSA) as im-
munogen and NT-3-carboxymethyloxime-OVA (NT-3-OVA) 
as coating antigen were conjugated in our laboratory. 
Freund’s complete adjuvant and Freund’s incomplete adju-
vant were obtained from Pierce. GaMIgG-HRP (whole mol-
ecule specific) was purchased from Sino-American Bio-
technology Company (Shanghai, China). Transparent 96- 
well polystyrene microtiter plates (Boyang Experimental 
Equipment Factory, Jiangsu, China) were used for the col-
orimetric measurement. Hypoxanthine/thymidine/aminop-    
terin and hypoxanthine/thymidine were obtained from Sigma- 
Aldrich (USA). RPMI-1640 with L-glutamine was obtained 
from Gibco. Polyethylene glycol 1500 (PEG 1500, 50%) 
was from Roche Diagnostics Corporation (Indianapolis, 
USA). Fetal bovine serum was from Hangzhou Sijiqing 
Biological Engineering Materials Co. Ltd. (Hangzhou, China). 
Cell culture plates (24 and 96 wells) and culture flasks were 
obtained from Costar Inc. (Bethesda, MD, USA). A mouse 
monoclonal antibody isotyping kit was purchased from 
Pierce Biotechnology, Inc. (Rockford, II, USA). 3,3,5,5-Tet-     
ramethylbenzidine (TMB), phenacetin, urea peroxide were 
obtained from Sigma Company. All other solvents and rea-
gents were of analytical grade or higher, unless otherwise 
stated.  
Eight-week-old female BALB/c mice were obtained 
from the Laboratory Animal Center, Beijing Medical Uni-
versity, China, and raised under strictly controlled condi-
tions in our laboratory. 
1.2  Buffers 
The buffers used were: phosphate buffered saline (PBS), 
consisting of NaCl (137 mmol/L), Na2HPO4·12H2O (10 
mmol/L), KCl (2.68 mmol/L) and KH2PO4 (1.47 mmol/L), 
pH 7.4; carbonate buffered saline (CBS) consisted of 
Na2CO3 (15 mmol/L), NaHCO3 (35 mmol/L), pH 9.6; 
washing buffer consisted of PBS containing 0.05% Tween- 
20; blocking buffer consisted of BSA (1%, w/v) in PBS. 
Substrate buffer consisted of adding part A (500 mL) and 
part B (500 mL) solutions together. Part A contained (per  
1 L of water) 3.15 g of citric acid, 6.966 g of anhydrous 
sodium acetate, 0.08 g of phenacetin and 0.05 g of urea 
peroxide adjusted to pH 5 with HCl. Part B contained 1.27 g 
TMB dissolved in 500 mL of methanol and 500 mL of 
glycerol. The stopping solution was 2 mol/L H2SO4. 
1.3  Instruments 
A spectrophotometric microtiter reader (MULTISKAN MK3, 
Thermo Company, USA), provided with a 450 nm filter, was 
used for absorbance measurements. Transferpettors (eLINE, 
Proline) were obtained from Biohit Company (Finland). A 
Legend Micro 17 microcentrifuge and GS15R high-speed 
refrigerated centrifuge were supplied by Thermo Company 
(USA). A CO2 incubator from RS-Biotech (Galaxy S+, UK) 
was used for cell cultivation. A SW-CJ-2FD Superclean 
Bench was purchased from Suzhou Purification Equipment 
Co., Ltd (Suzhou, China). An inverted microscope (TS100- 
F, Nikon Company, Japan) was used for cell observation. 
DK-8D thermostatic bathes were from Yiheng Instruments 
Co., Ltd (Shanghai, China). BS124S electronic balance was 
from the Sartorius Group (Germany). LDZX-30KB Steam 
Sterilizer was supplied by Shenan Medical Instrument Fac-
tory (Shanghai, China). Deionized water was prepared using 
an Ultra class UV plus water purification system (SG Com-
pany, Germany). Incubation for immunoreactions was car-
ried out in a DH-360A oven from Zhongxingweiye Instru-
ment Co., Ltd (Beijing, China). 
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1.4  General ELISA procedure   
The titer of the antibody was tested by indirect ELISA, us-
ing the procedure described below. The microplates were 
coated with coating antigen NT-3-OVA at 2 μg/mL (100 
μL/well) by overnight incubation at 4°C. Plates were 
washed with PBST three times and unbound active sites were 
blocked with 250 μL/well of blocking buffer, followed by 
incubation for 2 h at room temperature. The solution was 
then discarded, and plates were washed three times with 
washing solution. Fifty μL/well of appropriate dilution of 
the antisera was added, and the plates were incubated for 15 
min at 37°C. After another washing procedure, GaMIgG-HRP 
(1:1000, 50 μL/well) was added, followed by incubation for 
25 min at 37°C. The plates were washed, and 60 μL/well 
freshly prepared substrate solution A and B (1:1, v/v) was 
added. After incubating at room temperature for 15 min, the 
reaction was stopped using 2 mol/L H2SO4. The absorbance 
was measured at 450 nm and the antibody titer was defined 
as the reciprocal of the dilution that resulted in an absorb-
ance value that was twice that of the background. Absorb-
ances were corrected by blank readings (wells in which no 
primary antibody was added). 
Indirect competitive ELISA (icELISA) was employed to 
determine the sensitivity and specificity. Checkerboard tests 
were performed to determine optimal dilution of the coating 
antigen and the primary antibody, resulting in the following 
optimized protocol. Ninety-six well polystyrene ELISA 
plates were coated with 100 μL per well of OVA-conjugate 
solution, then received 50 μL per well of analyte in PBS 
containing 5% methanol plus 50 μL per well of hybridoma 
supernatant or purified antibody solution in PBST, unless 
otherwise stated. All samples were run in triplicate. The 
same procedure was followed for the indirect ELISA. With 
the inhibition ELISA format, analytes that do not react with 
the antibody would produce absorbance near 100%; con-
versely, analytes that do react with the antibody would de-
crease in percentage of absorbance. The inhibition rate was 
expressed as (B/B0)%, where B is the absorbance of the well 
containing the competitor and B0 is the absorbance of the 
well without the competitor. Standard curves were calculat-
ed by mathematically fitting experimental points to a four- 
parameter logistic equation. 
1.5  Immunization schedule   
Five BALB/c female mice (8–10 weeks old) were immun-
ized with NT-17-BSA conjugates by subcutaneously injec-
tions at multiple points. The first dose consisted of 60 μg of 
immunogen as an emulsion of PBS and Freund’s complete 
adjuvant. Three subsequent injections were given at 3-week 
intervals with the same dosage of immunogen emulsified in 
Freund’s incomplete adjuvant. After a resting period of at 
least 3 weeks from the last injection with adjuvant, mice 
were tail-bled and screened for anti-NT activity by icELISA. 
The mouse showing the highest anti-NT activity received a 
final soluble intraperitoneal injection of 100 μg of conjugate 
in PBS, 3–4 d prior to cell fusion. 
1.6  Fusion of myeloma and spleen cells   
Portions of the cell fusion procedures and cloning condi-
tions were described previously by Köhler and Milstein [18] 
with further modifications by Chen et al. [19]. Briefly, NS0 
myeloma cells were passed through a medium containing 
8-azaguanine and then grown for 4–5 d at 37°C in a 5% 
CO2 atmosphere. On the day of fusion, the mouse (that re-
ceived the booster injection) was sacrificed by cervical dis-
location and the spleen was removed aseptically. The sple-
nocytes were isolated and fused with myeloma cells at a 
10:1 ratio using PEG 1500 as the fusing agent, followed by 
gentle stirring for 1 min. The resulting mixture was kept 
still at 37°C for 1.5 min, and then 40 mL of hypoxanthine/ 
thymidine/aminopterin-1640 medium (supplemented with 
15% fetal bovine serum) was slowly added to the fused cells. 
The fused cells were then distributed into 96-well culture 
plates, in which mouse peritoneal macrophages were pre-
pared on the day before the fusion and were grown with the 
selective hypoxanthine/thymidine/aminopterin medium. 
1.7  Hybridoma production, selection, and cloning  
Ten–fourteen days after fusion, supernatants from hybridoma 
colonies were recovered and screened using a combination 
of noncompetitive and competitive, indirect ELISA. Well 
cultures showing significant NT recognition activity were 
expanded from the culture in the 96-well plate to a 24-well 
plate, and subcloned three times by limiting dilution. The 
wells picked for expansion were viewed under a microscope 
to confirm the presence of a single cell source to ensure 
their monoclonal origin, and the hypoxanthine/thymidine 
medium was gradually replaced by complete medium. After 
hybridomas became dense in the 24-well plate, they were 
transferred to 50 or 100 mL culture flasks. Hybridomas cells 
were collected, centrifuged and the supernatants were stored 
at −20°C until used. Colonies of interest were frozen in cul-
ture medium containing 10% dimethyl sulfoxide (DMSO) 
and cryopreserved in liquid nitrogen, followed by defrosting 
three times to select the stable antibody producing clones. 
1.8  Monoclonal antibody production  
A mature female BALB/c mouse was injected intraperito-
neally with 0.5 mL of paraffin 10 d before receiving an in-
traperitoneal injection of the positive hybridoma cells sus-
pended in RPMI 1640 medium. Ascitic fluid was collected 
10 d after the injection and then stored at −20°C until use. 
Purification of monoclonal antibody (mAb) was performed 
according to the modified caprylic acid ammonium sulfate 
precipitation (CAASP) method described before [20]. 
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1.9  Characterization of mAbs   
The purified antibody was immediately used for the charac-
terization. The protein content of the antibody was determined 
according to the following formula: protein concentration (mg/ 
mL)=1.45A280 nm − 1.74A260 nm, where A value is the optical 
density [21]. Measurement of monoclonal antibody affinity 
(Ka) was carried out according to the procedure described 
by Wang et al. [22]. The class and subclass of the isotypes 
of the purified antibody were determined by using a mouse 
monoclonal antibody isotyping kit. The calibration curves 
were fitted based on the average of three separate assays in 
triplicate. 
1.10  Establishment and optimization of icELISA   
The following values were evaluated to identify the icE-
LISA. The IC50 values were calculated to determine the sen-
sitivity, which represented the concentration of NT that 
produced 50% inhibition of antibody binding to the coating 
antigen. The detection limit of the assay was defined as the 
lowest concentration that exhibits a signal of 15% inhibition 
[23]. The dynamic range for the icELISA was calculated as 
the concentration of the analyte providing a 20%–80% inhi-
bition rate (IC20–IC80 values) of the maximum signal. Spec-
ificity was defined as the ability of structurally related 
chemicals to bind to the specific antibody [24] and cross- 
reactivity was calculated as: ((IC50 of NT)/(IC50 of analogs)) 
×100%. The lower the cross-reactivity is, the higher the 
specificity of NT mAb is. 
NT stock solution was prepared in PBS containing dif-
ferent concentrations of methanol. To optimize the schedule, 
the standards were prepared using 5%, 10%, 20%, 30%, and 
40% of methanol. The effects on icELISA standard curve 
were evaluated by Amax and IC50 values. 
1.11  Matrix effects in authentic urine sample   
Portions of the procedure were depicted earlier [25]. Briefly, 
a total of 10 mL of cattle urine sample was centrifuged at 
4°C with a speed of 3000 r/min for 10 min, and the super-
natant layer was transferred into a calibrated flask. In order 
to reduce the background and assess matrix interference, the 
urine sample was diluted in PBS (total 2, 5, 10 and 20-fold 
dilution) before they were applied to the microtiter plate. 
Typical experimental response curves were plotted for the 
absorbance values against the different concentrations of 
NT. B and B0 values from each diluted curve were com-
pared with that generated from the PBS to determine the 
appropriate urine dilution. 
1.12  LC-MS/MS determination   
In this study, we followed the method described by Strahm 
et al. [26], with significant modifications. Briefly, 10 mL of 
urine sample was centrifuged at 3500 r/min for 5 min, and a 
volume of 10 mL acetate buffer (pH 5.2, 0.2 mol/L) was 
added into the supernatant. The mixture was then subjected 
to enzymatic hydrolysis with 50 μL of β-glucuronidase 
from E. coli (Sigma-Aldrich, USA) and incubated on an 
oscillator at 37°C for 6 h. The mixture was then extracted 
with 10 mL of methanol and submitted to solid-phase for 
the clean-up process. The SPE C18 cartridges (Dalian Sipore 
Co., Ltd., China) were consecutively conditioned with 5 mL 
of methanol and then 5 mL of deionized water at a flow rate of 
0.3 mL/min. After loading with the aqueous extract solution, 
the cartridge was washed with 10 mL of the elution solution 
(n-hexane- ether [70:30, v/v]) at a flow rate of less than 0.5 
mL/min. After centrifugation, the organic layer was re-
moved under a stream of nitrogen in a water bath at 45°C, 
and the extracts were redissolved in methanol for further 
analysis. 
The LC-MS/MS analysis were performed on a SURVEYOR 
liquid chromatograph (Thermo Company, USA), equipped 
with a PDA plus Detector (Thermo Finnigan, USA) and a 
Thermo ODS-HYPERSIL column (3 μm, 2.1 × 150 mm). 
Analytes were separated using a mobile phase solution of 
1% formic acid in water/acetonitrile/methanol (60:20:20, 
pH 2.5) at a constant temperature of 30°C and a flow rate of 
0.2 mL/min. The ultraviolet detector was operated at 242 nm 
and the injection volume was 10 μL. Mass spectrometry 
was performed using a mass spectrometer equipped with a 
TurbolonSpray ESI source (LCQ Deca XP MAX, Finnigan 
Company, USA). Positive chemical ionization (PCI) mode 
was used and the relative collision energy was optimized to 
28%. A pseudo-molecular ion [M + H]
+ was selected as the 
parent ion for fragmentation, and the corresponding frag-
ment ions were used for identification and quantitation. 
2  Results 
2.1  Selection for potential cell-fused mice 
Five mice were immunized with the NT-17-BSA conjugate 
following the standard protocols described above, while 
NT-3-OVA were coated onto ELISA plates to determine the 
titer and inhibition level of antisera. After three subsequent 
injections, four of the five mice immunized with NT-17- 
BSA produced antisera with significant anti-NT activities 
(Figure 1). From the inhibition curves obtained, N0.4 mouse 
afforded the most sensitive IC50 value (17.5 ng/mL) and it 
was selected for further use. 
2.2  Production of monoclonal antibodies 
Ten days following the fusion, growing hybridoma cell 
clones could be observed in many wells of the seeded 96- 
well plates. The fusion rate of the mouse spleen cells with 
myeloma cells was about 85%. Supernatants of all wells 
were screened by simultaneous noncompetitive and competi-
tive assays, and the positive well rate was 18%. Selection 
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Figure 1  Inhibitive curves of NT antisera against NT by indirect compet-
itive ELISA. 
of clones from these positive cultures by limiting dilution 
led to five stable hybridoma cell lines. These monoclonal 
cultures and their corresponding cell lines were named 
NT-1, NT-2, NT-3, NT-4 and NT-5. Using a mouse mono-
clonal antibody isotyping kit, all five antibodies were of the 
IgG1 isotype with k light chain. The protein concentrations 
of all mAbs were between 5.6 and 8.4 mg/mL. Finally, five 
hybridomas were expanded and stored in liquid nitrogen. 
The mAbs from culture supernatants and ascites were puri-
fied and characterized. Based on the results of the checker-
board titration, the antibody titers and IC50 values were de-
termined. The results are shown in Table 1. From the inhi-
bition curves obtained, the most sensitive hybridomas, 
named NT-1 and NT-2, showed the IC50 values of 0.55 and 
0.58 ng/mL, respectively. This means that the sensitivity of 
mAb increased approximately 30 fold in comparison to that 
of the NT pAb tested before. Therefore, NT-1 hybridoma 
was selected for further evaluation of mAb specificity and 
subsequent immunoassay development. 
2.3  Hybridoma stability experiments 
Five hybridoma cell lines that produced the antibodies of 
interest were identified by stability verification. After three 
times of frozen and defrosted procedure, the performances 
of NT-1 and NT-2 hybridomas were more consistent in the 
experiments. The results are shown in Figure 2. 
2.4  Determination for the affinity constant (Ka) of NT 
mAbs 
The affinity constant produced by each of the five selected 
hybridomas was measured by ELISA using serial dilutions 
of both coated antigen and NT mAb. The optimal condition 
of ELISA in which the A value was about 1.0 was selected. 
The apparent Kas of NT-1, NT-2, NT-3, NT-4 and NT-5 
mAb were 4.7×109, 4.2×109, 3.9×109, 2.9×109 and 2.6×109 
L/mol, respectively (Figure 3). 
Table 1  Titers and IC50 results of mAbs produced by five hybridomas 
Monoclonal 
antibody 
Titer of culture  
supernatants 
Titer of  
ascites 
IC50 values of  
ascites (ng/mL) 
NT-1 5.12×102 2.56×105 0.55 
NT-2 5.12×102 2.56×105 0.58 
NT-3 2.56×102 1.28×105 0.8 
NT-4 1.28×102 1.28×105 0.93 
NT-5 1.28×102 0.64×105 1.0 
 
 
Figure 2  IC50 values of NT mAb generated from five selected hybrido-
mas after three defrosted times.  
 
Figure 3  Affinity constant (Ka) curves of NT mAbs. 
2.5  Establishment of heterologous icELISA standard 
curve 
From the checkerboard titration (data not shown), a repre-
sentative standard inhibition curve is shown in Figure 4. In 
this assay, NT-17-BSA was employed as the immunogen 
and NT-3-OVA was used as the coating antigen to pursue 
the heterologous sensitivity. Based on the results, the opti-
mum concentration of coating antigen was 2 μg/mL and 
mAb was 1:50000 dilutions. This assay allowed the detec-
tion of NT (20%–80% inhibition of color development) 
from 0.004 to 85.8 ng/mL, with an IC50 value of 0.55 ng/mL. 
The detection limit of the assay was 0.002 ng/mL. 
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Figure 4  Optimized standard heterologous icELISA inhibition curve for 
NT. Data were obtained by averaging three independent curves, each run in 
triplicate. NT-3-OVA (2 μg/mL) as a coating antigen was prepared in CBS 
(pH 9.6), purified ascites produced by NT-1 hybridoma was diluted 
1:50000 in PBS (pH 7.4), NT was prepared in PBS containing 10% of 
methanol, GaMIgG-HRP was diluted 1:1000 in incubation buffer.  
2.6  Cross-reactivity of NT analogs 
Investigations on cross-reactivity of the antibody obtained 
are crucial for assessing the results. Therefore, a number of 
compounds, structurally related to NT, were tested with 
icELISA to characterize the properties of the antibody. Figure 
5 shows all of the candidate compounds examined in this 
paper. Of all the cross-reacting steroids, α-NT had the highest 
cross-reactivity data (62%), but negligible cross- reactivity 
(<0.01%) with the other steroids was observed. 
2.7  Effects of methanol in assay buffer 
NT is difficultly dissolved in water; therefore, suitable hy-
drotropic solvents are needed. Methanol is a commonly 
used agent for this, so it was used in this study. The effects 
were estimated by running standard curves under various 
conditions. The maximum absorbance (Amax, the absorbance 
value at zero concentration of NT) and half-maximum inhi-
bition concentration (IC50 values) were calculated, and the 
results are shown in Figure 6. Based on the results, 10% 
methanol is suitable for this study. 
2.8  Matrix effects in urine samples 
It has been known that various substances in urine can af-
fect antigen-antibody interaction in immunoassays. Dietary 
components, higher ionic strengths and the pH values 
strongly suppress the IC50 value and the maximum absorb-
ance. When we tried to analyze urine samples without any 
pretreatment, spiked samples gave a very high background 
signal, resulting in an apparent absorbance decrease. A 
comparison between calibration plots for NT prepared in 
PBS and those prepared in different dilutions of urine gave 
clear evidence of a matrix effect (Figure 7). It was found 
that the 1:20 dilution in cattle urine gives inhibition curve 
that are almost the same as that of PBS. 
2.9  Correlation studies between icELISA and LC-MS/ 
MS analysis 
The objective was to compare the results obtained from 
ELISA with those from LC-MS/MS to determine the effec-
tiveness of the icELISA method developed here. Therefore, 
cattle urine spiked samples were analyzed to obtain a direct 
comparison between the two methods. The results showed 
that the icELISA method gave a good correlation with the 
LC-MS/MS results (R2 = 0.9871, shown in Figure 8), indi-
cating the accuracy of the icELISA method developed here. 
Consequently, there was no risk of a false-positive result 
during the analysis of urine samples by the icELISA. 
To further validate the immunoassay for detecting 19- 
nortestosterone residues, authentic urine was assessed by 
collecting 15 samples from a local abattoir and subjecting 
them to icELISA and comparing the results with LC- 
MS/MS analysis. The results showed that the residue levels 
ranged from 0.06 to 0.35 μg/kg (0.06–0.35 ng/mL) for ELISA, 
compared with 0.05–0.32 μg/kg (0.05–0.32 ng/mL) for 
LC-MS/MS. This means that the immunoassay developed 
here can be reliably used for real sample analysis. 
 
Figure 5  Cross-reactivity of structurally related steroids in the NT immunoassay. 
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Figure 6  Effects of methanol concentrations on immunoassay. Each 
point represents the mean of three replicates. 
 
Figure 7  NT standard curves in the diluted urine samples. PBS (■), 
2-fold dilution (▲), 5-fold dilution (◆), 10-fold dilution (★), 20-fold dilu-
tion (●). Each point represents the average of three separate assays done in 
triplicate. 
 
Figure 8  Correlation studies between ELISA detection and LC-MS/MS 
detection in cattle urine samples fortified with different concentrations of NT. 
3  Discussion 
Binding capacity, sensitivity, affinity and specificity deter-
mine the main immunity characteristics of an antibody, and 
immunoassays are based on the reciprocal conjugating ac-
tivity between antigen and antibody. The polyclonal anti-
body (pAb) usually contains unrelated or other antigenic 
immunoglobulin, as well as a mixture of products induced 
by different antigen determinants. Therefore, the quality 
differences in pAb causes difficulties for the immunoassay 
method. A homogeneous and unlimited supply of mAb be-
came available following the development of the hybridoma 
technique by Köhler and Milstein [18]. Using this technol-
ogy, we have screened five hybridoma cell lines in which 
two constant strains, named NT-1 and NT-2, had the highest 
titer (1:2.56×105) and sensitivity (0.55 and 0.58 ng/mL). 
Based on the NT-1 hybridoma, a heterologous icELISA 
standard curve has been developed for detecting NT residue 
in cattle urine. 
The affinity constant (Ka) of the antibody has an im-
portant effect on the quality of NT mAb. It demonstrates the 
conjugating ability between the antibody (Ab) and hapten, 
or one antigen determinant, and is a significant signal of 
antibody stability. Thus it is important to be able to measure 
Ka. The ordinary methods include equilibrium dialysis, 
Scatchard plot, Batty saturation method, competitive bind-
ing, the precipitation method and other methods. The Batty 
saturation method used in this article is simple, rapid, and 
reliable. The use of serial dilutions of Ab resulted in a sig-
moid curve of A versus the logarithm of total Ab added to 
the well. The A-50 values for different antibodies were a 
reflection of the relative number of epitopes on the Ag that 
were identified by different antibody paratopes, provided 
excessive mAb was used. According to James [27], the five 
hybridomas all produced high-affinity antibodies (between 
107 and 1012 L/mol). 
It is essential to produce highly molecular or structurally 
specific antibodies to NT hapten in the immunoassay. Het-
erologous icELISA was employed to judge the cross-reac-     
tivity of constant NT-1 mAb, in which the hapten-OVA 
conjugate used for plate coating was synthesized by a 
mixed-anhydride technique and the immunogen was pre-
pared by employing a C-17 coupled steroid-protein conju-
gate through EDC method, thus overcoming unwanted cross- 
reactivity (nonspecific binding) [28,29]. It is believed that 
the hapten- or antigen-antibody interaction is dependent on 
the spatial structure defined by molecular shape and geome-
try complementary bonding, and on low-energy interactions 
such as hydrogen bonding, hydrophobic interaction, and 
electrostatic or dipole–dipole forces. For our cross-reactivity 
data, the results were expected, considering that α-NT and 
NT have very similar chemical structure while other analogs 
have an extra alkyl group, double bond or chlorine atom on 
the cyclopentano perhydro-phenanthrene, resulting in obvi-
ous steric hindrance. 
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